A trial of RSV immune globulin in infants and young children: the FDA's view.
Ellenberg
S S
SS
Epstein
J S
JS
Fratantoni
J C
JC
Scott
D
D
Zoon
K C
KC
D015982:Bias; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007231:Infant, Newborn; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D014481:United States; D014486:United States Food and Drug Administration
D016756:Immunoglobulins, Intravenous